Results 81 to 90 of about 100,497 (232)

Aid to Fight AIDS: An Empirical Analysis of HIV‐Specific Development Aid Effectiveness

Scottish Journal of Political Economy, EarlyView.
ABSTRACT Using an excludable instrument for HIV‐specific aid, we investigate its effectiveness on HIV outcomes viz., prevalence and death rates. We theorize that HIV‐specific aid fills the funding gap that prevents governments from committing adequate resources to effectively address the epidemic.
Derek Nolan, Krishna Chaitanya Vadlamannati   +1 more
wiley   +1 more source

Highly Active Antiretroviral Therapy Interruption

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
To characterize the magnitude and the predictors of highly active antiretroviral therapy (HAART) interruption (TI) and to investigate its immunologic and virological consequences.Using Concerted Action on Seroconversion to AIDS and Death in Europe data from 8,300 persons with well-documented seroconversion dates, we identified subjects with stable ...
Touloumi, G, Pantazis, N, Antoniou, A, Stirnadel, H, Walker, SA, Porter, K   +5 more
openaire   +2 more sources

Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users. [PDF]

, 2012
Objectives  To identify factors influencing mortality in an HIV programme providing care to large numbers of injecting drug users (IDUs) and patients co-infected with hepatitis C (HCV).
ATC Collaboration, Bassetti, Benhamou, Bonnet, Braitstein, Celentano, Chander, Chen, Chun, Coetzee, Collett, Ding, Dore, Dou, Ferradini, Garten, Gebo, Grambsch, Gross, Kerr, Knowlton, Liu, Martinez, Mills, Mohsen, National Center for AIDS/STD Control and Prevention., Nelson, Pujades-Rodriguez, Rhodes, Smit, Tassie, Te, Wainberg, Werb, Wood, Wood, Wood, Zachariah, Zhang   +38 more
core   +2 more sources

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions

Transplant Infectious Disease, EarlyView.
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni, Andrea Cona, Malgorzata Mikulska, Francesca Pecoraro, Carlotta Piazza, Elda De Vita, Giada Pietrosi, Matteo Bulati, Tiziana Lazzarotto, Mario Luppi   +9 more
wiley   +1 more source

Low-Level HIV-I Replication and the Dynamics of the Resting CD4(+) T Cell Reservoir for HIV-I in the Setting of HAART [PDF]

, 2008
In the setting of highly active antiretroviral therapy (HAART), plasma levels of human immunodeficiency type-I (HIV-I) rapidly decay to below the limit of detection of standard clinical assays.
Sedaghat, Ahmad R., Siliciano, Robert F., Wilke, Claus O.   +2 more
core   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, Volume 39, Issue 3, Page 346-367, April 2026.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Social Representations of Aids and of the Antiretroviral Therapy for People Living with HIV

Psicologia, 2008
The aim of this study was to characterize the social representation of Aids and Highly Active Antiretroviral Therapy (HAART) for people living with HIV that have adherence to treatment, users of the public health services of Florianópolis, Santa Catarina.
Tatiana de Lucena Torres, Brígido Vizeu Camargo   +1 more
doaj  

A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients

Brazilian Journal of Infectious Diseases
Darunavir (DRV) is an HIV-1 protease inhibitor that is used together with a low boosting dose of ritonavir as part of an antiretroviral therapy (ART) regimen in treatment-experienced and naïve HIVpositive patients.
Massimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, Andrea Calcagno, Sandro Vento   +4 more
doaj   +1 more source

Assessment of quality of life in a cohort of newly diagnosed patients on haart regimen, in resource restricted tribal region of chhattisgarh, India: A prospective study

Journal of Global Infectious Diseases, 2013
Background: Highly active antiretroviral therapy regimens have resulted in the systemic/clinical healing for human immune deficiency virus-infected patients but the consequence of antiretroviral therapy on the whole quality of life has become a major ...
Harminder Singh, Kamalpreet Kaur, Navin Dulhani, Akash Bansal, Bithika N Kumar, Vinod Kumar Singh Chouhan   +5 more
doaj   +1 more source

Spontaneous apoptosis and highly active antiretroviral therapy (HAART)

Biomedicine & Pharmacotherapy, 2000
Increased programmed cell death (PCD) or apoptosis has been detected in the T cells of HIV-infected subjects; it is held partially responsible for the continuous loss of CD4+ T cells during the natural course of HIV infection. Highly active antiretroviral therapy (HAART) decreases the viral load and leads to an increase of CD4+ count in vivo.
Dieye, Tandakha, Van Vooren, Jean-Paul, Delforge, Marie-Luce, Liesnard, Corinne, Devleeschouwer, Michel, Farber, Claire   +5 more
openaire   +2 more sources